Earlier this month, we published an article that highlighted a few of our favorite international cannabis markets.
Included in the list was Israel which we continue to view as an attractive long-term growth opportunity. During the last two years, the Israeli industry has recorded major advancements and we believe the market is in the early innings of a major growth cycle.
Earlier this year, a few Canadian Licensed Producers (LPs) reported that a much higher percentage of quarterly revenue was derived from the Israeli cannabis market. Over the coming years, we expect the trend to become more significant and believe Israel will be one of the largest cannabis markets outside of North America.
Today, we highlighted 5 Canadian companies which are focused on capturing a larger share of Israel’s cannabis market. Although we are bullish on Israel, having leverage to the country does not a make a company a good business and we want our readers to be aware of that when reading this article.
- A few months ago, Cronos Group (Nasdaq: CRON) (TSX: CRON) reported quarterly earnings and recorded strong revenue growth in Israel. We believe the Canadian LP is well positioned to capitalize on Israel and expect the business to report a higher percentage of revenue from the market in future quarters. We expect Cronos to be a long-term beneficiary of the growth of Israel’s cannabis market and will monitor how the story advances in 2023 and beyond.
- In late 2020, Aurora Cannabis Inc. (Nasdaq: ACB) (TSX: ACB) entered the Israeli cannabis market via a two-year strategic supply agreement with Cantek Holdings. So far, the relationship has proven to be a great opportunity for the Canadian cannabis producer to expand its medical cannabis brand as well as its intellectual property portfolio. Last year, Aurora Cannabis reported what it believed to be the largest shipment of medical cannabis to Israel to-date and we expect the market to play a more significant role for the business in the years ahead.
- Earlier this month, SNDL Inc. (Nasdaq: SNDL) reported to have completed its initial international export of approximately 167 kilograms of premium dried flower from Canada to Israel as part of its total commitment with IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC). The companies previously agreed to export 1,000 kilograms of dried flower products for processing and distribution in Israel. SNDL believes the emerging international cannabis market provides it with an opportunity to increase revenue from its cannabis operations and we will monitor how this side of the business ramps up.
- We consider Aleafia Health Inc. (TSX: AH) (OTC: ALEAF) to be a Canadian LP that is flying under the radar and have been impressed with how it has executed on a multi-national growth strategy. In late 2020, Aleafia Health announced a binding letter of intent (LOI) with Equinox International Ltd., to start exporting cannabis to Israel. We believe the market does not assign much value to the Canadian LP’s international business and will monitor how this aspect of the story evolves from here.
- HEXO Corporation (NYSE: HEXO) (TSX: HEXO) is viewed as an early mover on the Israeli cannabis market and was one of the first large-scale Canadian LPs to focus on the emerging market. In mid-2020, the company announced a strategic supply agreement with Breath of Life (BOL) and we expected the relationship to serve as a major growth driver for the business. During the last year, HEXO has been under heavy pressure and we will monitor how the management team tries to get the business back on track.
If you are interested in learning more about companies that are capitalizing on the Israeli cannabis market, please send an email to support@technical420.com with the subject “Leading Israeli Cannabis Operators” to be added to our distribution list.
Comments